News
GSK wins FDA priority review for Promacta supplemental new...
GlaxoSmithKline, Ligand Pharmaceuticals' partner, has gained FDA priority review status for the supplemental new drug application for Promacta to treat thrombocytopenia in adult patients...
News
Catalent begins supply of Abilify antipsychotic drug to Otsuka...
Catalent has started supplying its antipsychotic drug, Abilify, an orally disintegrating tablet (ODT) to Otsuka Pharmaceutical. Abilify ODT, which utilizes...
News
Bloodstream scavenger inhibits clotting without increased bleeding
A compound that mops up debris of damaged cells from the bloodstream may be the first in a new class of drugs designed to...
News
Novartis gains FDA approval for Afinitor® in advanced breast...
The US Food and Drug Administration (FDA) has approved Afinitor® (everolimus) tablets* (approval represents the first major advance for US patients with advanced HR+...
News
AstraZeneca to initiate a new study of BRILINTA in...
AstraZeneca announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately...
News
GSK to acquire Human Genome Sciences for US$14.25 per...
GlaxoSmithKline plc and Human Genome Sciences have entered into a definitive agreement under which GSK will acquire HGS for US$14.25 per share in cash....
News
GSK and Theravance announce regulatory submissions for FF/VI
GlaxoSmithKline plc (GSK) and Theravance, Inc. announced the submission of regulatory applications in the US and European Union for the once-daily investigational medicine fluticasone...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.